Publication list - Publika - Scientific publications from Oslo University Hospital

Publications by Anne Olaug Olsen

35 publications found

Original articles

Nerlander L, Champezou L, Gomes Dias J, Aspelund G, Berlot L, Constantinou E, Díaz A, Epštein J, Fogarassy E, Hernando V, Hoffmann P, Igoe D, Klavs I, Pinto Leite P, Liitsola K, McIntyre A, Molnár Z, Olsen AO, Pires-Afonso Y, Putniņa R, Rudaitis K, Siakallis G, de Stoppelaar S, Suligoi B, Hannila-Handelberg T et al. (2024)
Sharp increase in gonorrhoea notifications among young people, EU/EEA, July 2022 to June 2023
Euro Surveill, 29 (10)
DOI 10.2807/1560-7917.ES.2024.29.10.2400113, PubMed 38456219

Brendefur Corwin LM, Campbell P, Jakobsen K, Müller F, Lai X, Unemo M, Leegaard TM, Vildershøj Bjørnholt J, Olsen AO (2023)
Improvement in Neisseria gonorrhoeae culture rates by bedside inoculation and incubation at a clinic for sexually transmitted infections
Ann Clin Microbiol Antimicrob, 22 (1), 27
DOI 10.1186/s12941-023-00576-0, PubMed 37072830

Skjælaaen K, Nesvold H, Brekke M, Sare M, Landaas ET, Mdala I, Olsen AO, Vallersnes OM (2022)
Sexually transmitted infections among patients attending a sexual assault centre: a cohort study from Oslo, Norway
BMJ Open, 12 (12), e064934
DOI 10.1136/bmjopen-2022-064934, PubMed 36456026

North S, Sandset TJ, Olsen AO (2021)
A cross-sectional survey of general practitioner knowledge, attitudes, and clinical experience of HIV PrEP
J. Public Health-Heidelberg
DOI 10.1007/s10389-021-01626-7

Alfsnes K, Eldholm V, Olsen AO, Brynildsrud OB, Bohlin J, Steinbakk M, Caugant DA (2020)
Genomic epidemiology and population structure of Neisseria gonorrhoeae in Norway, 2016-2017
Microb Genom, 6 (4)
DOI 10.1099/mgen.0.000359, PubMed 32213251

Orumaa M, Kjaer SK, Dehlendorff C, Munk C, Olsen AO, Hansen BT, Campbell S, Nygård M (2020)
The impact of HPV multi-cohort vaccination: Real-world evidence of faster control of HPV-related morbidity
Vaccine, 38 (6), 1345-1351
DOI 10.1016/j.vaccine.2019.12.016, PubMed 31917039

Unemo M, Salado-Rasmussen K, Hansen M, Olsen AO, Falk M, Golparian D, Aasterød M, Ringlander J, Nilsson CS, Sundqvist M, Schønning K, Moi H, Westh H, Jensen JS (2017)
Clinical and analytical evaluation of the new Aptima Mycoplasma genitalium assay, with data on M. genitalium prevalence and antimicrobial resistance in M. genitalium in Denmark, Norway and Sweden in 2016
Clin Microbiol Infect, 24 (5), 533-539
DOI 10.1016/j.cmi.2017.09.006, PubMed 28923377

Danielsen K, Wilsgaard T, Olsen AO, Furberg AS (2017)
Overweight and Weight Gain Predict Psoriasis Development in a Population-based Cohort
Acta Derm Venereol, 97 (3), 332-339
DOI 10.2340/00015555-2530, PubMed 27602427

Molin SB, De Blasio BF, Olsen AO (2016)
Is the risk for sexually transmissible infections (STI) lower among women with exclusively female sexual partners compared with women with male partners? A retrospective study based on attendees at a Norwegian STI clinic from 2004 to 2014
Sex Health, 13 (3), 257-64
DOI 10.1071/SH15193, PubMed 27050292

Nilsen E, Aasterød M, Hustad PS, Olsen AO (2016)
Mecillinam against genital Chlamydia trachomatis infection: a small-scale proof-of-concept study shows a low cure rate
J Antimicrob Chemother, 71 (8), 2270-2
DOI 10.1093/jac/dkw134, PubMed 27165786

Wold C, Sorthe J, Hartgill U, Olsen AO, Moghaddam A, Reinton N (2015)
Identification of macrolide-resistant Mycoplasma genitalium using real-time PCR
J Eur Acad Dermatol Venereol, 29 (8), 1616-20
DOI 10.1111/jdv.12963, PubMed 25622510

Danielsen K, Wilsgaard T, Olsen AO, Eggen AE, Olsen K, Cassano PA, Furberg AS (2014)
Elevated odds of metabolic syndrome in psoriasis: a population-based study of age and sex differences
Br J Dermatol, 172 (2), 419-27
DOI 10.1111/bjd.13288, PubMed 25059341

Melby KK, Olsen AO, Dedi L, Gaustad P, Syversen G, Moi H (2014)
[The development of resistance must be monitored--gonococci as an example]
Tidsskr Nor Laegeforen, 134 (5), 507-8
DOI 10.4045/tidsskr.14.0033, PubMed 24621906

Reinton N, Moi H, Olsen AO, Zarabyan N, Bjerner J, Tønseth TM, Moghaddam A (2013)
Anatomic distribution of Neisseria gonorrhoeae, Chlamydia trachomatis and Mycoplasma genitalium infections in men who have sex with men
Sex Health, 10 (3), 199-203
DOI 10.1071/SH12092, PubMed 23751932

Danielsen K, Olsen AO, Wilsgaard T, Furberg AS (2013)
Is the prevalence of psoriasis increasing? A 30-year follow-up of a population-based cohort
Br J Dermatol, 168 (6), 1303-10
DOI 10.1111/bjd.12230, PubMed 23374051

Unemo M, Golparian D, Skogen V, Olsen AO, Moi H, Syversen G, Hjelmevoll SO (2012)
Neisseria gonorrhoeae strain with high-level resistance to spectinomycin due to a novel resistance mechanism (mutated ribosomal protein S5) verified in Norway
Antimicrob Agents Chemother, 57 (2), 1057-61
DOI 10.1128/AAC.01775-12, PubMed 23183436

Gervin K, Vigeland MD, Mattingsdal M, Hammerø M, Nygård H, Olsen AO, Brandt I, Harris JR, Undlien DE, Lyle R (2012)
DNA methylation and gene expression changes in monozygotic twins discordant for psoriasis: identification of epigenetically dysregulated genes
PLoS Genet, 8 (1), e1002454
DOI 10.1371/journal.pgen.1002454, PubMed 22291603

Moi H, Vestrheim DF, Olsen AO (2011)
[Reduce the use of one-dose azithromycin]
Tidsskr Nor Laegeforen, 131 (7), 673-4
DOI 10.4045/tidsskr.10.1224, PubMed 21494300

Grjibovski AM, Olsen AO, Magnus P, Harris JR (2007)
Psoriasis in Norwegian twins: contribution of genetic and environmental effects
J Eur Acad Dermatol Venereol, 21 (10), 1337-43
DOI 10.1111/j.1468-3083.2007.02268.x, PubMed 17958839

Olsen AO, Grjibovski A, Magnus P, Tambs K, Harris JR (2005)
Psoriasis in Norway as observed in a population-based Norwegian twin panel
Br J Dermatol, 153 (2), 346-51
DOI 10.1111/j.1365-2133.2005.06613.x, PubMed 16086747

Kristiansen M, Helland A, Kristensen GB, Olsen AO, Lønning PE, Børresen-Dale AL, Ørstavik KH (2003)
X chromosome inactivation in cervical cancer patients
Cancer Genet Cytogenet, 146 (1), 73-6
DOI 10.1016/s0165-4608(03)00152-3, PubMed 14499700

Lie AK, Skarsvåg S, Haugen OA, Skjeldestad FE, Olsen AO, Skovlund E, Rønningen KS (1999)
Association between the HLA DQB1*0301 gene and human papillomavirus infection in high-grade cervical intraepithelial neoplasia
Int J Gynecol Pathol, 18 (3), 206-10
DOI 10.1097/00004347-199907000-00003, PubMed 12090587

Olsen AO, Dillner J, Skrondal A, Magnus P (1998)
Combined effect of smoking and human papillomavirus type 16 infection in cervical carcinogenesis
Epidemiology, 9 (3), 346-9
DOI 10.1097/00001648-199805000-00022, PubMed 9583429

Helland A, Olsen AO, Gjøen K, Akselsen HE, Sauer T, Magnus P, Børresen-Dale AL, Rønningen KS (1998)
An increased risk of cervical intra-epithelial neoplasia grade II-III among human papillomavirus positive patients with the HLA-DQA1*0102-DQB1*0602 haplotype: a population-based case-control study of Norwegian women
Int J Cancer, 76 (1), 19-24
DOI 10.1002/(sici)1097-0215(19980330)76:1<19::aid-ijc4>3.0.co;2-0, PubMed 9533756

Olsen AO, Orstavik I, Dillner J, Vestergaard BF, Magnus P (1998)
Herpes simplex virus and human papillomavirus in a population-based case-control study of cervical intraepithelial neoplasia grade II-III
APMIS, 106 (3), 417-24
DOI 10.1111/j.1699-0463.1998.tb01366.x, PubMed 9548432

Olsen AO, Dillner J, Gjøen K, Magnus P (1997)
Seropositivity against HPV 16 capsids: a better marker of past sexual behaviour than presence of HPV DNA
Genitourin Med, 73 (2), 131-5
DOI 10.1136/sti.73.2.131, PubMed 9215097

Gjøen K, Sauer T, Olsen AO, Orstavik I (1997)
Correlation between polymerase chain reaction and cervical cytology for detection of human papillomavirus infection in women with and without dysplasia
APMIS, 105 (1), 71-5
DOI 10.1111/j.1699-0463.1997.tb00542.x, PubMed 9063504

Anderson TI, Wooster R, Laake K, Collins N, Warren W, Skrede M, Elles R, Tveit KM, Johnston SR, Dowsett M, Olsen AO, Møller P, Stratton MR, Børresen-Dale AL (1997)
Screening for ESR mutations in breast and ovarian cancer patients
Hum Mutat, 9 (6), 531-6
DOI 10.1002/(SICI)1098-1004(1997)9:6<531::AID-HUMU6>3.0.CO;2-4, PubMed 9195227

Olsen AO, Dillner J, Gjøen K, Sauer T, Orstavik I, Magnus P (1996)
A population-based case-control study of human papillomavirus-type-16 seropositivity and incident high-grade dysplasia of the uterine cervix
Int J Cancer, 68 (4), 415-9
DOI 10.1002/(SICI)1097-0215(19961115)68:4<415::AID-IJC2>3.0.CO;2-3, PubMed 8945608

Gjøoen K, Olsen AO, Magnus P, Grinde B, Sauer T, Orstavik I (1996)
Prevalence of human papillomavirus in cervical scrapes, as analyzed by PCR, in a population-based sample of women with and without cervical dysplasia
APMIS, 104 (1), 68-74
DOI 10.1111/j.1699-0463.1996.tb00688.x, PubMed 8645461

Olsen AO, Gjøen K, Sauer T, Orstavik I, Naess O, Kierulf K, Sponland G, Magnus P (1995)
Human papillomavirus and cervical intraepithelial neoplasia grade II-III: a population-based case-control study
Int J Cancer, 61 (3), 312-5
DOI 10.1002/ijc.2910610306, PubMed 7729940